Biomarin Pharmaceutical Inc (BMRN)

NASDAQ HEALTHCARE
$53.81 +1.18% RSI 45 Neutral Add Alert

Moving Averages

SMA 200
$56.56
Price below

Company Profile

BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$10.49B
P/E Ratio
30.29
EPS
$1.8
Beta
0.291
Dividend Yield
0.00%
52-Week High
$66.28
52-Week Low
$50.76

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: April 11, 2026 at 6:40 AM EDT

Track BMRN for free

Get e-mail RSI alerts when Biomarin Pharmaceutical Inc enters oversold or overbought territory. Free forever.

Add Alert